Warfarin Dosing Changes After Bariatric Surgery: Implications on the Mechanism for Altered Dose Requirements and Safety Concerns—An Alternative Viewpoint
- 3 April 2014
- journal article
- alternative viewpoint
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 34 (4) , e26-e29
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacologic and Mechanical Strategies for Preventing Venous Thromboembolism After Bariatric SurgeryJAMA Surgery, 2013
- Assessment of Warfarin Dosing Requirements After Bariatric Surgery in Patients Requiring Long‐Term Warfarin TherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Warfarin Users Prone to Coagulopathy in First 30 Days After Hospital Discharge from Gastric BypassObesity Surgery, 2013
- Parenteral AnticoagulantsChest, 2012
- Substitution of dalteparin with enoxaparin—a cautionary noteSurgery for Obesity and Related Diseases, 2010
- Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical SettingsAnnals of Pharmacotherapy, 2009
- Warfarin Resistance After Total Gastrectomy and Roux‐en‐Y EsophagojejunostomyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Hemorrhagic and Thromboembolic Complications after Bariatric Surgery in Patients Receiving Chronic Anticoagulation TherapyObesity Surgery, 2008
- Development of a dosing strategy for enoxaparin in obese patientsBritish Journal of Clinical Pharmacology, 2003
- In Vivo and In Vitro Availability of Commercial Warfarin TabletsJournal of Pharmaceutical Sciences, 1971